oncovax

News

Vaccinogen Alerts


You can automatically receive Vaccinogen News alerts. Please enter your name and e-mail address below, then click "Submit" - As news items are posted, they will be sent to you via e-mail.

First Name

Last Name

Email address (required)



Click Here for the
Vaccinogen Press Kit


October 22, 2009

Vaccinogen Announces New Relationship with CRO Clinipace Worldwide

July 24, 2009

Vaccinogen Announces Submission of Final Documentation to Swissmedic for Pivotal Review of OncoVAX®

July 17, 2009

Vaccinogen Announces That Michael G. Hanna, Jr., Ph.D. is Scheduled to Speak at the Vaccine Discovery & Development Conference in Brussels, Belgium in November

May 15, 2009

Vaccinogen Announces Establishment of a Distribution Relationship with Deutsches Grunes Kreuz ("DGK") for Distribution of OncoVAX in Germany

April 20, 2009

Vaccinogen Announces That Michael G. Hanna, Jr., Ph.D. is Scheduled to Speak at the Barcelona Vaccine Forum 2009 in June 2009

March 1, 2009

Vaccinogen Announces Addition of David Hatt to its Board of Directors

November 14, 2008

Vaccinogen Announces that Swissmedic Health Authorities Granted Its Swiss Distribution Partner, ProVaccine, Permission to Export Biopsies and Import Vaccines on behalf of Vaccinogen.

November 13, 2008

OncoVAX, Other Vaccines Provide Hope for Colorectal Cancer Treatment, Prevention

June 4, 2008

Thomson Reuters' Pharma Matters highlights Vaccinogen’s OncoVAX® as “One to Watch”

May 7, 2008

Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine;
License Clears Path to European Production, Final FDA Trial

February 27, 2008

Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year

February 11, 2008

Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX®

November 10, 2007

Vaccinogen Announces the Successful Acquisition of Key Management and Staff 

November 4, 2007

Vaccinogen Announces Successful Acquisition of cGMP Manufacturing Facility

November 3, 2007

Vaccinogen Announces Completion of its Initial Capitalization Plan

October 1, 2007

Vaccinogen Announces Formation of Company

July 19, 2006

FDA Grants Special Protocol Assessment

July, 2006

FDA Grants Intracel “Fast Track ” Designation for the Development of Its Colon Cancer Vaccine



Site credit: idfive, the interactive division of growth5